Skip to main content

Fibrogen Inc CS(FGEN-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Fibrogen Inc CS

409 ILLINOIS STREET
SAN FRANCISCO CA 94158 USA
P: 415-978-1200
F: 415-978-1902
http://www.fibrogen.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.

    Key Executives

    NameTitle
    Information not available.